| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Cheryl Wang | |
| P2860 | cites work | Insulin-sensitive obesity | Q43008676 |
| Effects of aerobic training on serum omentin-1 and cardiometabolic risk factors in overweight and obese men. | Q43026599 | ||
| Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery | Q43106771 | ||
| Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes | Q43174951 | ||
| Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure | Q43183441 | ||
| ZAG, a lipid mobilizing adipokine, is downregulated in human obesity | Q43540191 | ||
| Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway | Q43673852 | ||
| The serum levels of adiponectin and leptin in mustard lung patients | Q43769126 | ||
| Acute respiratory distress syndrome in nontrauma surgical patients: a 6-year study | Q43826196 | ||
| Decreased levels of serum omentin-1 in patients with obstructive sleep apnoea syndrome | Q43901982 | ||
| Profiles of pro-inflammatory cytokines in the serum of rabbits after experimentally induced acute pancreatitis | Q43910438 | ||
| Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes : the Leiden 85-Plus Study | Q43935453 | ||
| Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance | Q44039988 | ||
| Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. | Q44453195 | ||
| Cloning of adiponectin receptors that mediate antidiabetic metabolic effects | Q24304889 | ||
| Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action | Q24307700 | ||
| Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity | Q24532873 | ||
| T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin | Q24564272 | ||
| An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist | Q24606097 | ||
| From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines | Q27008912 | ||
| The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor | Q27748941 | ||
| Secreted Frizzled-related protein potentiation versus inhibition of Wnt3a/β-catenin signaling | Q28115695 | ||
| Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance | Q28131660 | ||
| Adiponectin and future coronary heart disease events among men with type 2 diabetes | Q28213958 | ||
| Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma | Q28268844 | ||
| The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin | Q28585701 | ||
| A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes | Q28590335 | ||
| Macrophage inhibitory cytokine 1 (MIC-1/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets | Q28730588 | ||
| Prevalence and trends in obesity among US adults, 1999-2008 | Q29547759 | ||
| Macrophages, inflammation, and insulin resistance | Q29614351 | ||
| Incidence and outcomes of acute lung injury | Q29615139 | ||
| Interleukin-1-receptor antagonist in type 2 diabetes mellitus | Q29619001 | ||
| Omentin: a novel link between inflammation, diabesity, and cardiovascular disease | Q30404638 | ||
| Influence of body mass index on outcome of the mechanically ventilated patients. | Q44899215 | ||
| Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice | Q45302054 | ||
| Comparative effects of metformin and pioglitazone on omentin and leptin concentrations in patients with newly diagnosed diabetes: a randomized clinical trial. | Q45860858 | ||
| Long-term impact of vertical banded gastroplasty (VBG) on plasma concentration of leptin, soluble leptin receptor, ghrelin, omentin-1, obestatin, and retinol binding protein 4 (RBP4) in patients with severe obesity. | Q45901732 | ||
| Association between serum vaspin level and metabolic syndrome in healthy Korean subjects. | Q45917982 | ||
| Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss. | Q45977375 | ||
| High serum vaspin concentrations in patients with ulcerative colitis. | Q46036744 | ||
| Serum omentin levels in patients with obstructive sleep apnea | Q46152330 | ||
| Inhibition of NADPH oxidase by vaspin may prevent progression of atherosclerosis | Q46558148 | ||
| Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors. | Q46570541 | ||
| Melatonin and omentin: influence factors in the obstructive sleep apnoea syndrome? | Q46883562 | ||
| Serum vaspin concentrations in human obesity and type 2 diabetes | Q46908191 | ||
| Elevated levels of high-molecular-weight adiponectin in type 1 diabetes | Q47232277 | ||
| Omentin inhibits TNF-α-induced expression of adhesion molecules in endothelial cells via ERK/NF-κB pathway | Q47329442 | ||
| Association between adiponectin and mediators of inflammation in obese women. | Q48007188 | ||
| Adiponectin increases insulin content and cell proliferation in MIN6 cells via PPARγ-dependent and PPARγ-independent mechanisms. | Q49171559 | ||
| Induction of adiponectin in skeletal muscle of type 2 diabetic mice: In vivo and in vitro studies | Q33237890 | ||
| Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype | Q33673519 | ||
| Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms | Q33688706 | ||
| Enhanced metabolic flexibility associated with elevated adiponectin levels | Q33703749 | ||
| Cardiomyocyte-derived adiponectin is biologically active in protecting against myocardial ischemia-reperfusion injury | Q33727436 | ||
| Obesity and lung inflammation | Q33728039 | ||
| Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study | Q33803480 | ||
| Circulating omentin concentration increases after weight loss | Q33810842 | ||
| Adipose tissue mass and location affect circulating adiponectin levels | Q33878077 | ||
| Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. | Q33976184 | ||
| Design and development of a peptide-based adiponectin receptor agonist for cancer treatment | Q34040946 | ||
| The association between BMI and plasma cytokine levels in patients with acute lung injury | Q34130717 | ||
| Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects | Q34182705 | ||
| Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer | Q34202639 | ||
| Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion | Q34231901 | ||
| Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance | Q34303280 | ||
| Metformin Treatment May Increase Omentin-1 Levels in Women With Polycystic Ovary Syndrome | Q34355173 | ||
| Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue | Q34480822 | ||
| APPL1 mediates adiponectin-stimulated p38 MAPK activation by scaffolding the TAK1-MKK3-p38 MAPK pathway | Q34501820 | ||
| Chemerin and vaspin: possible targets to treat obesity? | Q34529446 | ||
| ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism | Q34537657 | ||
| Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study | Q34665113 | ||
| Body mass index is associated with the development of acute respiratory distress syndrome | Q34956191 | ||
| Adipose tissue remodeling and obesity | Q35015740 | ||
| Effects of macrophage-specific adiponectin expression on lipid metabolism in vivo | Q35086818 | ||
| Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity | Q35095489 | ||
| Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. | Q35101294 | ||
| Host innate defenses in the lung: the role of cytokines | Q35160604 | ||
| Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study | Q35528297 | ||
| Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo | Q35611417 | ||
| Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome | Q35638490 | ||
| Adiponectin attenuates lipopolysaccharide-induced acute lung injury through suppression of endothelial cell activation | Q35658773 | ||
| Pulmonary endothelium in acute lung injury: from basic science to the critically ill. | Q35838918 | ||
| Emerging roles for the transforming growth factor-{beta} superfamily in regulating adiposity and energy expenditure | Q36003155 | ||
| Characterization of the Wnt inhibitors secreted frizzled-related proteins (SFRPs) in human adipose tissue. | Q50796370 | ||
| Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus. | Q51377789 | ||
| Serum zinc-alpha2-glycoprotein correlates with adiposity, triglycerides, and the key components of the metabolic syndrome in Chinese subjects. | Q51427415 | ||
| Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects. | Q51481080 | ||
| Circulating and adipose tissue gene expression of zinc-alpha2-glycoprotein in obesity: its relationship with adipokine and lipolytic gene markers in subcutaneous and visceral fat. | Q51608081 | ||
| Exudate macrophages attenuate lung injury by the release of IL-1 receptor antagonist in gram-negative pneumonia. | Q54390257 | ||
| Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. | Q54594898 | ||
| Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. | Q54790389 | ||
| Omentin plasma levels and gene expression are decreased in obesity. | Q55043420 | ||
| Adiponectin and Coronary Heart Disease | Q57416324 | ||
| Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis | Q57752623 | ||
| The Relationship between Insulin Resistance and the Cardiovascular Biomarker Growth Differentiation Factor-15 in Obese Patients | Q58788278 | ||
| Erratum: corrigendum: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects | Q59054562 | ||
| The adipokine zinc-α2-glycoprotein (ZAG) is downregulated with fat mass expansion in obesity | Q64134402 | ||
| Adenovirus-mediated gene transfer of human interleukin 10 ameliorates reperfusion injury of rat lung isografts | Q64380336 | ||
| Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor | Q71961272 | ||
| Anti-inflammatory effect of interleukin-10 in rabbit immune complex-induced colitis | Q77124124 | ||
| IT 9302, a synthetic interleukin-10 agonist, diminishes acute lung injury in rabbits with acute necrotizing pancreatitis | Q77297295 | ||
| Determinants of serum adiponectin in persons with and without type 1 diabetes | Q80526890 | ||
| Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy | Q81569172 | ||
| Clinical significance of serum growth differentiation factor-15 levels in systemic sclerosis: association with disease severity | Q82909747 | ||
| Is zinc-α2-glycoprotein a cardiovascular protective factor for patients undergoing hemodialysis? | Q83006467 | ||
| Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway | Q83768753 | ||
| Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study | Q83915344 | ||
| Omentin plays an anti-inflammatory role through inhibition of TNF-α-induced superoxide production in vascular smooth muscle cells | Q84066267 | ||
| A synthetic peptide homologous to IL-10 functional domain induces monocyte differentiation to TGF-β+ tolerogenic dendritic cells | Q84161032 | ||
| Macrophage-secreted factors inhibit ZAG expression and secretion by human adipocytes | Q84512101 | ||
| Binding of adiponectin and C1q in human serum, and clinical significance of the measurement of C1q-adiponectin / total adiponectin ratio | Q84595470 | ||
| Studies on the anti-obesity activity of zinc-α2-glycoprotein in the rat | Q85057901 | ||
| Vaspin attenuates high glucose-induced vascular smooth muscle cells proliferation and chemokinesis by inhibiting the MAPK, PI3K/Akt, and NF-κB signaling pathways | Q86403258 | ||
| Low omentin-1 levels are related with clinical and metabolic parameters in obese children | Q86425475 | ||
| Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition | Q36068357 | ||
| Therapeutic perspectives of adipocytokines | Q36161243 | ||
| DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer. | Q36471888 | ||
| Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies | Q36476496 | ||
| Alveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice | Q36619374 | ||
| Adiponectin in pulmonary disease and critically ill patients | Q36714296 | ||
| A tangled threesome: adiponectin, insulin sensitivity, and adiposity: can Mendelian randomization sort out causality? | Q36720590 | ||
| Zinc-α2-glycoprotein is associated with insulin resistance in humans and is regulated by hyperglycemia, hyperinsulinemia, or liraglutide administration: cross-sectional and interventional studies in normal subjects, insulin-resistant subjects, and s | Q36782703 | ||
| Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure | Q36989465 | ||
| Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases. | Q37056669 | ||
| Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. | Q37133445 | ||
| Activation of human mesenchymal stem cells impacts their therapeutic abilities in lung injury by increasing interleukin (IL)-10 and IL-1RN levels | Q37255056 | ||
| Subtyping obesity with microarrays: implications for the diagnosis and treatment of obesity | Q37396373 | ||
| Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. | Q37400702 | ||
| Acute lung injury review | Q37472720 | ||
| White adipose tissue overproduces the lipid-mobilizing factor zinc α2-glycoprotein in chronic kidney disease. | Q37609992 | ||
| Adiponectin protects against hyperoxic lung injury and vascular leak | Q37723787 | ||
| Zinc-α2-glycoprotein: an adipokine modulator of body fat mass? | Q37761828 | ||
| Vascular effects of novel adipocytokines: focus on vascular contractility and inflammatory responses | Q37849490 | ||
| Lipid mobilization in cachexia: mechanisms and mediators | Q37936152 | ||
| Dietary factors and low-grade inflammation in relation to overweight and obesity | Q37963508 | ||
| Models and mechanisms of acute lung injury caused by direct insults | Q37979492 | ||
| Adiponectin: mechanistic insights and clinical implications | Q38017897 | ||
| Obesity epidemic: how to make a difference in a busy OB/GYN practice | Q38020011 | ||
| Adipokines in obesity | Q38082962 | ||
| Role of adiponectin in the metabolic syndrome: current perspectives on its modulation as a treatment strategy | Q38085396 | ||
| Anti-inflammatory cytokines and risk of type 2 diabetes. | Q38134103 | ||
| Role of β-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-α2-glycoprotien (ZAG). | Q38328919 | ||
| Studies on the antiobesity effect of zinc-α2-glycoprotein in the ob/ob mouse. | Q38341793 | ||
| Combined effects of body mass index and cardio/respiratory fitness on serum vaspin concentrations in Korean young men. | Q38349771 | ||
| Role of tumor necrosis factor in sepsis and acute lung injury | Q38608518 | ||
| Adiponectin is associated with dynamic hyperinflation and a favourable response to inhaled glucocorticoids in patients with COPD. | Q39218838 | ||
| Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial | Q39564409 | ||
| Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. | Q39720264 | ||
| Lower zinc-alpha2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance. | Q39822478 | ||
| Adiponectin is synthesized and secreted by human and murine cardiomyocytes. | Q40378261 | ||
| A synthetic peptide homologous to functional domain of human IL-10 down-regulates expression of MHC class I and Transporter associated with Antigen Processing 1/2 in human melanoma cells | Q40494549 | ||
| Time course of cytokine levels in sepsis | Q40990075 | ||
| Role of cytokines in sepsis. | Q41610123 | ||
| Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein | Q42811136 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| inflammation | Q101991 | ||
| chest trauma | Q368370 | ||
| pulmonary injury | Q7259546 | ||
| physiological phenomenon | Q66615932 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 978463 | |
| P577 | publication date | 2014-05-11 | |
| P1433 | published in | Mediators of Inflammation | Q2144494 |
| P1476 | title | Obesity, inflammation, and lung injury (OILI): the good. | |
| P478 | volume | 2014 |
| Q36447066 | 4-Isopropyl-2,6-bis(1-phenylethyl)aniline 1, an Analogue of KTH-13 Isolated from Cordyceps bassiana, Inhibits the NF-κB-Mediated Inflammatory Response |
| Q89777175 | Adipose-derived exosomes protect the pulmonary endothelial barrier in ventilator-induced lung injury by inhibiting the TRPV4/Ca2+ signaling pathway |
| Q47731845 | Association of T lymphocyte immune imbalance and IL-10 gene polymorphism with the risk of obstructive sleep apnea in children with obesity |
| Q90163240 | Differences in the Outcome of Patients with COPD according to Body Mass Index |
| Q39005558 | Effects of gliclazide add on metformin on serum omentin-1 levels in patients with type 2 diabetes mellitus. |
| Q55035051 | Hepatic steatosis associated with decreased β-oxidation and mitochondrial function contributes to cell damage in obese mice after thermal injury. |
| Q35675874 | Monitoring of Serial Presurgical and Postsurgical Changes in the Serum Proteome in a Series of Patients with Calcific Aortic Stenosis |
| Q55360178 | Obesity, Inflammation, Toll-Like Receptor 4 and Fatty Acids. |
| Q37330863 | Omentin protects against LPS-induced ARDS through suppressing pulmonary inflammation and promoting endothelial barrier via an Akt/eNOS-dependent mechanism |
| Q47650367 | Omentin-A Novel Adipokine in Respiratory Diseases. |
| Q40342338 | RAGE/NF-κB signaling mediates lipopolysaccharide induced acute lung injury in neonate rat model |
| Q91274436 | Serum Adipokine Levels in Patients Considered for Lung Transplantation |
| Q47670217 | Serum Levels of Visfatin, Omentin and Irisin in Patients with End-Stage Lung Disease Before and After Lung Transplantation. |
| Q35691513 | T, B, and NKT Cells in Systemic Inflammation in Obstructive Sleep Apnoea. |
| Q54107821 | The Wnt antagonist and secreted frizzled-related protein 5: implications on lipid metabolism, inflammation and type 2 diabetes mellitus. |
| Q35926491 | The relationship between serum fatty-acid binding protein 4 level and lung function in Korean subjects with normal ventilatory function. |
| Q46283198 | Vaspin protects against LPS‑induced ARDS by inhibiting inflammation, apoptosis and reactive oxygen species generation in pulmonary endothelial cells via the Akt/GSK‑3β pathway |
| Q88333470 | [Vaspin protects against lipopolysaccharide-induced acute respiratory distress syndrome in mice by inhibiting inflammation and protecting vascular endothelium via PI3K/Akt signal pathway] |
Search more.